Femasys Corp (FEMY) - Multiplikator forward rega marang pendapatan
Stable system assembly in the US has minimized logistical risks for Femasys Inc. (FEMY). The business's forward P/S reflects current valuation trends, where 5.10 represents the latest metric reading. Growth prospects are based on the implementation of FemaSeed and FemBloc systems. The uniqueness of non-operative diagnostic methods will enable the company to independently determine the pricing power of its innovative products for clinics.
Femasys Corporation - rincian analitis lan metrik utama (FEMY)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Femasys Inc.|FEMY - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Femasys Inc.|FEMY - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Femasys Corporation|FEMY - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Femasys|Rasio cepet femasys.com
- data bathi bisnis lan rasio investasi:
FEMY - Penghasilan resik perusahaan|Bathi sing dikarepake Femasys Inc.|FEMY - Koefisien rega marang bathi|Pangali Forward P/E Femasys Corp|FEMY - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Femasys Corporation|FEMY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Femasys|FEMY - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan femasys.com|FEMY - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Femasys Inc.
- data dodolan lan asil:
Analisis umum perusahaan:FEMY (Femasys)
This indicator correlates current market capitalization with projected forward sales for the year, allowing for an assessment of whether the asset is overvalued or undervalued relative to future cash flows. By analyzing the forward price-to-sales ratio, an investor can determine the extent to which the market currently prices in the success of Femasys Inc. (FEMY) organic expansion into the gynecological sector, excluding external acquisitions.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|ATRC: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan STAA (STAAR Surgical Co)|NAGE (ChromaDex Corporation) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep zimvie.com ZIMV|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|Multiplikator forward rega marang pendapatan Cerus Corp. CERS|Multiplikator Forward P/S TKNO (Alpha Teknova Inc)|Multiplikator Forward P/S Monogram Orthopedics Inc. MGRM|STSS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake InfuSystem Holdings INFU|UTMD (Utah Medical Products, Inc.) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep KORU Medical (KRMD)|Rasio rega marang prakiraan pendapatan Nyxoah, S.A.|Microbot Medical, Inc (MBOT) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PDEX (Pro-Dex, Inc.)|ZTEK (zentek.com) - Rega forward marang dodolan|Multiplikator Forward P/S ELUT (Elutia)|Rasio kapitalisasi marang dodolan sing dikarepake Milestone Scientific Inc (MLSS)|NXGL - Rasio rega marang prakiraan pendapatan|RVP (Retractable Technologies) - Kapitalisasi marang prakiraan pendapatan|HBIO: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Meihua Medical Technologies Co., Ltd.|Multiplikator forward rega marang pendapatan POAI|Callan JMB Corp (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ATRI|NURO: Rega mangsa ngarep marang pendapatan
